Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
ATLAS experiment wikipedia , lookup
Double-slit experiment wikipedia , lookup
Compact Muon Solenoid wikipedia , lookup
Path integral formulation wikipedia , lookup
Standard Model wikipedia , lookup
Relativistic quantum mechanics wikipedia , lookup
Theoretical and experimental justification for the Schrödinger equation wikipedia , lookup
Identical particles wikipedia , lookup
Using Ludiflash® in Roll Compaction to produce Orally Dispersible Acetaminophen Granules T. Agnese1, T. Cech1, M. G. Herting2 European Pharma Application Lab, E-mail: [email protected], BASF SE, 67056 Ludwigshafen, Germany Pharma Ingredients & Services Europe, BASF SE, 67056 Ludwigshafen, Germany Materials As active ingredient, acetaminophen powder (Fagron GmbH & Co. KG, Barsbüttel, Germany) was used. As excipients, Ludiflash® (composed of mannitol [90 %], Kollicoat® SR 30 D [5 % solids] and Kollidon® CL-SF [5 %]) and Kollidon® CL-SF from BASF SE, Ludwigshafen, Germany, were used. Sucralose (Splenda®, McNeil Nutritionals, Ft. Washington PA, USA) and strawberry flavour (Symrise AG, Holzminden, Germany) were added. Formulation The formulations listed in Table 1 were tested. Table 1: Formulations – amounts in [mg] #1 #2 #3 #4 Acetaminophen 500.0 500.0 500.0 500.0 Ludiflash® 716.2 653.7 591.2 528.7 – 62.5 125.0 187.5 Sucralose 18.8 18.8 18.8 18.8 Strawberry flavour 15.0 15.0 15.0 15.0 1,250.0 1,250.0 1,250.0 1,250.0 Kollidon® CL-SF Total weight Methods The formulation contains a high dosage of the poorly compressible acetaminophen (40 %). Additionally, sucralose as a sweetener, strawberry flavour and Ludiflash® as DC excipient were used in the granular formulation. The content of Kollidon® CL-SF as additional extragranular disintegrant was varied to investigate its influence on granule’s particle size distribution (PSD) and granule strength. All excipients were passed through a roll compactor applying specific compaction forces of 6, 9, 12, 15 and 18 kN/cm. As roll compactor, the Mini-Pactor® (Gerteis, Jona, Switzerland) was used with the settings listed in Table 2. 80 70 60 Cross strip 11 rpm Particle size distribution The test was performed with a sieve tower Retsch AS 200 (Retsch GmbH, Haan, Germany) by using sieves in the range of 90–1,400 µm (according to Ph. Eur.) applying an amplitude of 1.5 mm/’g’ for 15 minutes. 27670 APGI_MD313_DruckA3.indd 1 0.4 0.2 0 50 40 200 400 600 800 1,000 1,200 1,400 Particle size [mg] 6 kN/cm 9 kN/cm 12 kN/cm 15 kN/cm 18 kN/cm Figure 4: Cumulative particle size distribution of formulation #3 as function of compression force 1.0 0.8 0.6 0.4 0.2 30 0.0 20 0 200 400 10 600 800 1,000 1,200 1,400 Particle size [mg] 0 6 9 12 15 18 6 #1 9 12 15 18 6 9 12 15 18 6 #2 9 12 15 18 #3 #4 Formulation / compression force [kN/cm2] Figure 1: Friability of granules after 15 minutes testing time (mean ± s; n = 2) Comparing the data at a compression force of 15 kN, the addition of Kollidon® CL-SF led to stronger granules indicated by lower friability (Figure 1). Furthermore, the addition of the extragranular disintegrant influenced the particle size distribution as well. The more Kollidon® CL-SF was added to the formulation, the coarser were the resulting granules (Figure 2– Figure 5). Additionally, the difference in PSD of formulation #1 found for the different compression forces (Figure 2) could be reduced. The dependency of PSD on compression force could distinctively be reduced as soon as Kollidon® CL-SF was present in the formulation and a specific compaction force of at least 9 kN/cm was applied. Regardless of the positive effect of Kollidon® CL-SF on the physical characteristics of the granule, its amount in the formulation has to be chosen with care. If the content was too high, the mouth feeling would begin to get unpleasant. This would be due to the fact that a huge quantity of saliva is being absorbed by this insoluble excipient. 1.0 0.8 0.6 0.4 0.2 0.0 200 400 600 800 1,000 1,200 1,400 Particle size [mg] 6 kN/cm 9 kN/cm 12 kN/cm 15 kN/cm 18 kN/cm Figure 2: Cumulative particle size distribution of formulation #1 as function of compression force 1.0 Cumulative distribution [-] Star 30 rpm, 40 rpm 180°, 160° 1.5 mm, 1.5 mm 0.6 0.0 Independent of the amount of Kollidon CL-SF in the powder blend, the compaction of Ludiflash® could be conducted without any problems. Depending on the compression force, granule’s strength could decisively be influenced (Figure 1) whereby the higher the force the stronger the granules. 0 Smooth, smooth 250 mm, 25 mm 1 rpm 0.8 ® Table 2: Parameter settings for the roll compactor Rolls Master, slave Diameter, width Speed Granulator Rotor type Rotation speed CW, CCW Angel CW, CCW Mesh width, sieve gap Powder bridge breaker Type Speed Cumulative distribution [-] Results and Discussion Cumulative distribution [-] Materials and Methods 1.0 0.8 0.6 0.4 0.2 0.0 0 200 400 600 800 1,000 1,200 1,400 Particle size [mg] 6 kN/cm 9 kN/cm 12 kN/cm 15 kN/cm 18 kN/cm Figure 3: Cumulative particle size distribution of formulation #2 as function of compression force 6 kN/cm 9 kN/cm 12 kN/cm 15 kN/cm 18 kN/cm Figure 5: Cumulative particle size distribution of formulation #4 as function of compression force After roll compaction, one could consider it useful to separate fine from coarse particles. These fines could be retuned to the feeder to undergo a second compaction run. However, in this investigation for all granules, a clear dependency of drug content on particle size could be found (Figure 6). This could lead to a change in drug content of the granules over the processing time. 45 Acetaminophen content [%] Delivering active ingredients via orally dispersible tablets (ODTs) is a current trend in the pharmaceutical industry. Due to the easy and fast application, patient’s compliance is high for this kind of dosage form. Ludiflash® is a direct compression (DC) vehicle intended for an easy formulation of ODTs [1]. Interestingly, granules packaged in sachets showed similar patient’s compliance as with ODTs. This work was to investigate the usability of Ludiflash® in dry granulation to produce granules containing acetaminophen. Friability An air jet sieve LPS 200 (Rhewum GmbH, Remscheid, Germany) assembled with a 125 µm sieve was used to determine both residual fines (remaining un-agglomerated particles) and friability of the granules [2]. Friability [%] Purpose Cumulative distribution [-] 1 2 40 35 30 25 0 200 400 600 800 1,000 1,200 1,400 1,600 Mesh size [µm] Figure 6: Content uniformity of sieve fractions, formulation #1, compressed with 12 kN/cm (mean ± s; n = 2) Conclusion The experiments showed that orally dispersible granules could easily be produced in roll compaction by using Ludiflash® or its combination with Kollidon® CL-SF. A clear dependency of granular strength and PSD on applied compaction force could be found. On the other hand, the addition of Kollidon® CL-SF caused the PSD to become less dependent on the applied force. Furthermore, the amount of fines could be reduced. However, too high amounts of Kollidon® CL-SF can cause an unpleasant mouth feeling due to huge amounts of saliva absorbed. References [1] Kruse, S.; Gebert, S.; Meyer-Böhm, K.; Maschke, A.; Kolter, K.; Compression Characterization and lubricant sensitivity of orally disintegrating tablets based on Ludiflash®; 2008; BASF SE, Ludwigshafen, Germany [2] Agnese, T.; Mittwollen, J.-P.; Kolter, K.; Herting, M. G.; An Innovative Method to Determine the Strength of Granules; AAPS Annual Meeting and Exposition; Nov. 16–20, 2008; Atlanta, Georgia, U.S.A. 2nd Conference Innovation in Drug Delivery; October 3–6, 2010; Aix-en-Provence, France; G-EMP/MD313 23.09.10 08:21